Medical Tech Firm Brainlab Said to Pick Banks for German IPO
- Berenberg, Deutsche Bank and Morgan Stanley working with firm
- More banks could be added to the lineup ahead of IPO this year
Brainlab AG makes software for surgical and radiotherapy applications, serving 6,700 hospitals in 127 countries.
Source: Brainlab AG
This article is for subscribers only.
German medical technology company Brainlab AG has picked banks to advise on an initial public offering, which could value the firm between €2 billion ($2.1 billion) and €3 billion, according to people familiar with the matter.
The Munich-based company is working with Berenberg, Deutsche Bank and Morgan Stanley on the potential listing, said the people, who asked not to be identified because the discussions are private.